Market LIVE
Published markets; coverage varies by country
Product profile · United States

RYBELSUS

 ·  Patent Litigation & Settlement History ↓

IngredientSEMAGLUTIDE
Application typeNDA
Application213051
Product003
Dosage formTABLET
RouteORAL
Strength14MG
Approval date2019-09-20
Marketing statusPrescription
Status event—
ApplicantNOVO
Product source

Current GenericRadar decision

Year2031
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typePATENT
Anchor date2031-12-05
Patent anchor2031-12-05
Exclusivity anchor2022-12-05
Protection date2034-05-02
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2031. Anchor type: PATENT. Patent anchor: 2031-12-05. Exclusivity anchor: 2022-12-05. Anchor date: 2031-12-05. Patent tail: yes. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
85361222026-03-20DS/DP/U U-2628YNTRUE_DS
English description not available.
———
85361222026-03-20ORANGE_BOOK U-2628YNTRUE_DS
English description not available.
———
81293432031-12-05DS/DP/U U-2628YNTRUE_DS
English description not available.
———
81293432031-12-05ORANGE_BOOK U-2628YNTRUE_DS
English description not available.
———
100860472031-12-16DP —NNDP
English description not available.
———
100860472031-12-16ORANGE_BOOK —NNDP
English description not available.
———
109600522031-12-16DP —NNDP
English description not available.
———
109600522031-12-16ORANGE_BOOK —NNDP
English description not available.
———
113829572031-12-16DP —NNDP
English description not available.
———
113829572031-12-16ORANGE_BOOK —NNDP
English description not available.
———
92781232031-12-16DP/U U-2628NNDP
English description not available.
———
92781232031-12-16ORANGE_BOOK U-2628NNDP
English description not available.
———
109331202033-03-15DP —NNDP
English description not available.
———
109331202033-03-15ORANGE_BOOK —NNDP
English description not available.
———
117595012033-03-15DP —NNDP
English description not available.
———
117595012033-03-15ORANGE_BOOK —NNDP
English description not available.
———
117595022033-03-15DP —NNDP
English description not available.
———
117595022033-03-15ORANGE_BOOK —NNDP
English description not available.
———
117595032033-03-15DP —NNDP
English description not available.
———
117595032033-03-15ORANGE_BOOK —NNDP
English description not available.
———
125943262033-03-15DP —NNDP
English description not available.
———
125943262033-03-15ORANGE_BOOK —NNDP
English description not available.
———
110334992033-06-19DP/U U-2628NNDP
English description not available.
———
110334992033-06-19ORANGE_BOOK U-2628NNDP
English description not available.
———
102789232034-05-02U U-2628NNU
English description not available.
———
102789232034-05-02ORANGE_BOOK U-2628NNU
English description not available.
———
122397392034-05-02DS/DP/U U-2628NNU
English description not available.
———
122397392034-05-02ORANGE_BOOK U-2628NNU
English description not available.
———
125148222034-05-02U U-2628NNU
English description not available.
———
125148222034-05-02ORANGE_BOOK U-2628NNU
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NP2019-09-202022-09-20English description not available.YY2022-09-20
NCE
Full coverage date: 2022-09-20
Source
NCE2017-12-052022-12-05English description not available.YY2022-12-05
NCE
Full coverage date: 2022-12-05
Source
M-2522020-01-162023-01-16English description not available.NN—
NCE
Full coverage date: —
Source
I-9762025-10-172028-10-17English description not available.NN——Source
I-9762025-10-172028-10-17English description not available.NN—
NCE
Full coverage date: —
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (20)
TypeDateRoleBasisSource
PATENT2026-03-20HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2031-12-05CANONICAL_ANCHOREnglish description not available.Source
PATENT2031-12-16FTO_TAILEnglish description not available.Source
PATENT2031-12-16FTO_TAILEnglish description not available.Source
PATENT2031-12-16FTO_TAILEnglish description not available.Source
PATENT2031-12-16FTO_TAILEnglish description not available.Source
PATENT2033-03-15FTO_TAILEnglish description not available.Source
PATENT2033-03-15FTO_TAILEnglish description not available.Source
PATENT2033-03-15FTO_TAILEnglish description not available.Source
PATENT2033-03-15FTO_TAILEnglish description not available.Source
PATENT2033-03-15FTO_TAILEnglish description not available.Source
PATENT2033-06-19FTO_TAILEnglish description not available.Source
PATENT2034-05-02FTO_TAILEnglish description not available.Source
PATENT2034-05-02FTO_TAILEnglish description not available.Source
PATENT2034-05-02FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—HISTORICAL_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2031-12-05CANONICAL_DECISIONEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.